Female sex is linked to a stronger association between sTREM2 and CSF p-tau in Alzheimer’s disease
Open Access
- 10 January 2025
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 17 (2) , 235-248
Abstract
In Alzheimer’s disease (AD), Aβ triggers p-tau secretion, which drives tau aggregation. Therefore, it is critical to characterize modulators of Aβ-related p-tau increases which may alter AD trajectories. Here, we assessed whether factors known to alter tau levels in AD modulate the association between fibrillar Aβ and secreted p-tau 181 determined in the cerebrospinal fluid (CSF). To assess potentially modulating effects of female sex, younger age, and ApoE4, we included 322 ADNI participants with cross-sectional/longitudinal p-tau 181 . To determine effects of microglial activation on p-tau 181 , we included 454 subjects with cross-sectional CSF sTREM2. Running ANCOVAs for nominal and linear regressions for metric variables, we found that women had higher Aβ-related p-tau 181 levels. Higher sTREM2 was associated with elevated p-tau 181 , with stronger associations in women. Similarly, ApoE4 was related to higher p-tau 181 levels and faster p-tau 181 increases, with stronger effects in female ApoE4 carriers. Our results show that sex alone modulates the Aβ to p-tau axis, where women show higher Aβ-dependent p-tau secretion, potentially driven by elevated sTREM2-related microglial activation and stronger effects of ApoE4 carriership in women.Keywords
Funding Information
- LMU, FoeFoLe (1119)
- Hertie Foundation for Clinical Neurosciences
- SyNergy Excellence Cluster (EXC 2145/ID 390857198)
This publication has 93 references indexed in Scilit:
- A reproducible evaluation of ANTs similarity metric performance in brain image registrationNeuroImage, 2011
- The changing demographic pattern of multiple sclerosis epidemiologyThe Lancet Neurology, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2009
- Most rapid cognitive decline in APOE ε4 negative Alzheimer's disease with early onsetPsychological Medicine, 2009
- Early-Onset Dementia Is Associated with Higher MortalityDementia and Geriatric Cognitive Disorders, 2008
- Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascadeNeurobiology of Disease, 2005
- Apolipoprotein E ε4 and testosterone interact in the risk of Alzheimer's disease in menInternational Journal of Geriatric Psychiatry, 2002
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinBiochemical and Biophysical Research Communications, 1984